| 일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
| 2011/02/24 | 20:00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 20:00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 20:00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 06:40 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 06:40 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 06:39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 06:39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 06:39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 06:39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/24 | 06:38 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/23 | 07:06 | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/19 | 06:09 | Edgar (US Regulatory) | Post-effective Amendment to an automatic shelf registration of Form S-3ASR or Form F-3ASR (POSASR) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/19 | 06:07 | Edgar (US Regulatory) | Post-effective Amendment to an automatic shelf registration of Form S-3ASR or Form F-3ASR (POSASR) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/19 | 06:05 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/19 | 06:04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/19 | 06:04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/19 | 06:02 | Edgar (US Regulatory) | -National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/16 | 07:03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/16 | 01:57 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/15 | 09:07 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/15 | 03:52 | Edgar (US Regulatory) | Schedule 13G | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/11 | 04:36 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/10 | 20:08 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/10 | 08:08 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/10 | 08:07 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/10 | 08:07 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/10 | 08:06 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/10 | 08:06 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/10 | 08:04 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 2011/02/08 | 23:34 | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:KG | King Pharmaceuticals, Inc. |